Facebook Instagram X-twitter Linkedin

GLOW (GHK-CU 50MG + BPC157 10mg + TB500 10mg) – 70mg

Table of Contents

  • Quickstart Highlights

GLOW is a compounded research peptide stack combining GHK-Cu, BPC-157, and TB500, designed to support tissue regeneration, recovery, and overall cellular repair signaling. This blend is often explored for its potential synergistic effects on skin health, inflammation balance, and connective tissue recovery.

This guide outlines a subcutaneous protocol optimized for the 70 mg vial format.

  • Reconstitute: Add 5.0 mL bacteriostatic water → 14 mg/mL total concentration
  • Typical use range: 1–3 mg total blend per day (subcutaneous)
  • Easy measuring: At 14 mg/mL, 1 unit = 0.01 mL = 140 mcg total blend on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support tissue repair, collagen signaling, and recovery processes
  • Schedule: Daily injections or split dosing depending on recovery needs
  • Dose Range: 1–3 mg total GLOW blend per day
  • Cycle Use: Commonly used in 2–6 week cycles depending on recovery goals
  • Dosing Protocol

Suggested approach for the 70 mg vial format.

  • Start: 1 mg per day to assess tolerance
  • Target: 2–3 mg per day (single dose or split AM/PM)
  • Frequency: Once or twice daily (subcutaneous)
  • Vial Duration: One 70 mg vial typically lasts ~20–70 days, depending on dosing
  • Timing: Morning or evening; consistent daily timing preferred
  • Mechanism of Action

GLOW combines three bioactive peptides with complementary mechanisms:

  • GHK-Cu (Copper Peptide): Supports collagen synthesis, skin remodeling, angiogenesis, and antioxidant activity. Often studied for skin repair and anti-aging signaling effects.
  • BPC-157: Influences growth factor pathways, nitric oxide signaling, and tissue regeneration processes, particularly in muscles, tendons, and the gastrointestinal system.
  • TB500 (Thymosin Beta-4 fragment): Involved in cell migration, actin regulation, and tissue repair signaling, potentially supporting flexibility and recovery of soft tissues.

Together, this combination is designed to provide multi-pathway support for regeneration, inflammation modulation, and structural tissue repair processes in preclinical research contexts.

  • Potential Benefits & Side Effects

Observations based on preclinical and early research literature.

Potential Benefits:

  • May support faster recovery from soft tissue strain or injury
  • May improve skin texture, repair, and collagen-related signaling
  • May support joint, tendon, and muscle recovery processes
  • May assist in reducing inflammation-related recovery time

Possible Side Effects:

  • Mild injection-site irritation
  • Temporary fatigue or headache in some users
  • Water retention or mild flushing (occasionally reported with peptide stacks)
  • Long-term human safety data is limited; investigational use only